BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12059059)

  • 21. Screening for colorectal cancer in Italy: 2006 survey.
    Zorzi M; Falcini F; Fedato C; Grazzini G; de' Bianchi PS; Senore C; Vettorazzi M; Visioli C; Zappa M
    Epidemiol Prev; 2008; 32(2 Suppl 1):55-68. PubMed ID: 18770995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal cancer screening.
    Bretthauer M
    J Intern Med; 2011 Aug; 270(2):87-98. PubMed ID: 21575082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
    Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
    Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer. A randomized study.
    Rasmussen M; Kronborg O; Fenger C; Jørgensen OD
    Scand J Gastroenterol; 1999 Jan; 34(1):73-8. PubMed ID: 10048736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Offering people a choice for colorectal cancer screening.
    Senore C; Ederle A; Benazzato L; Arrigoni A; Silvani M; Fantin A; Fracchia M; Armaroli P; Segnan N
    Gut; 2013 May; 62(5):735-40. PubMed ID: 22442162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Participation in colorectal cancer screening: a review.
    Vernon SW
    J Natl Cancer Inst; 1997 Oct; 89(19):1406-22. PubMed ID: 9326910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychological effects of colorectal cancer screening: Participants
    Kirkøen B; Berstad P; Botteri E; Bernklev L; El-Safadi B; Hoff G; de Lange T; Bernklev T
    World J Gastroenterol; 2016 Nov; 22(43):9631-9641. PubMed ID: 27920484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Training general practitioners in flexible sigmoidoscopy to screen for colorectal cancer.
    Martin JA; Crotty B; Barbaro D; Higlett T; Zalcberg J
    ANZ J Surg; 2001 Dec; 71(12):715-9. PubMed ID: 11906385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial.
    Hoff G; Grotmol T; Skovlund E; Bretthauer M;
    BMJ; 2009 May; 338():b1846. PubMed ID: 19483252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
    Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
    Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II.
    Rasmussen M; Fenger C; Kronborg O
    Scand J Gastroenterol; 2003 Jan; 38(1):114-8. PubMed ID: 12608473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening.
    Berry DP; Clarke P; Hardcastle JD; Vellacott KD
    Br J Surg; 1997 Sep; 84(9):1274-6. PubMed ID: 9313712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for colorectal cancer in Italy, 2009 survey.
    Zorzi M; Baracco S; Fedato C; Grazzini G; Sassoli De' Bianchi P; Senore C; Visioli CB; Cogo C
    Epidemiol Prev; 2011; 35(5-6 Suppl 5):55-77. PubMed ID: 22166350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
    Graser A; Stieber P; Nagel D; Schäfer C; Horst D; Becker CR; Nikolaou K; Lottes A; Geisbüsch S; Kramer H; Wagner AC; Diepolder H; Schirra J; Roth HJ; Seidel D; Göke B; Reiser MF; Kolligs FT
    Gut; 2009 Feb; 58(2):241-8. PubMed ID: 18852257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventing colorectal cancer or early diagnosis: Which is best? A re-analysis of the U.S. Preventive Services Task Force Evidence Report.
    Swartz AW; Eberth JM; Strayer SM
    Prev Med; 2019 Jan; 118():104-112. PubMed ID: 30367971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flexible sigmoidoscopy as a colorectal cancer screening test in the general population: recruitment phase results of a randomized controlled trial in Lombardia, Italy.
    Andreoni B; Crosta C; Lotti M; Carloni M; Marzona L; Biffi R; Luca F; Pozzi S; Cenciarelli S; Senore C
    Chir Ital; 2000; 52(3):257-62. PubMed ID: 10932370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation.
    Senore C; Armaroli P; Silvani M; Andreoni B; Bisanti L; Marai L; Castiglione G; Grazzini G; Taddei S; Gasperoni S; Giuliani O; Malfitana G; Marutti A; Genta G; Segnan N
    Am J Gastroenterol; 2010 Jan; 105(1):188-98. PubMed ID: 19826409
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.